Partial splenic embolization is superior to intravenous somatostatin for decreasing portal pressure in cirrhotic patients: a dynamic self-controlled cohort study

References

• de Franchis R, Baveno VIF. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–752.
   PubMed Web of Science ®Google Scholar
• Quraishi MN, Khan F, Tripathi D. How we manage variceal hemorrhage in cirrhotic patients. Key practical messages from the British Guidelines. Pol Arch Med Wewn. 2016;126(3):174–184.
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65(1):310–335.
   PubMed Web of Science ®Google Scholar
• Hallemans R, Naeije R, Melot C, et al. Systemic and pulmonary haemodynamic effects of somatostatin. Lancet. 1981;1(8232):1270.
   PubMed Web of Science ®Google Scholar
• Villanueva C, Planella M, Aracil C, et al. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose. Am J Gastroenterol. 2005;100(3):624–630.
   PubMed Web of Science ®Google Scholar
• Sonnenberg A, West C. Somatostatin reduces gastric mucosal blood flow in normal subjects but not in patients with cirrhosis of the liver. Gut. 1983;24(2):148–153.
   PubMed Web of Science ®Google Scholar
• Sonnenberg GE, Keller U, Perruchoud A, et al. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects. Gastroenterology. 1981;80(3):526–532.
   PubMed Web of Science ®Google Scholar
• Jenkins SA. Somatostatin in acute bleeding oesophageal varices. Clinical evidence. Drugs. 1992;44(2):36–55.
   PubMedGoogle Scholar
• Gotzsche PC, Hrobjartsson A. Somatostatin analogues for acute bleeding oesophageal varices. Cochrane Database Syst Rev. 2008;(3):CD000193.
   PubMedGoogle Scholar
• D’Amico G, Pagliaro L, Pietrosi G, et al. Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients. The Cochrane Database of Systematic Reviews. 2010;(3):CD002233.
   Google Scholar
• Banares R, Albillos A, Rincon D, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology. 2002;35(3):609–615.
   PubMed Web of Science ®Google Scholar
• Duan X, Zhang K, Han X, et al. Comparison of percutaneous transhepatic variceal embolization (PTVE) followed by partial splenic embolization versus PTVE alone for the treatment of acute esophagogastric variceal massive hemorrhage. J Vasc Interv Radiol. 2014;25(12):1858–1865.
   PubMed Web of Science ®Google Scholar
• Ohmoto K, Yoshioka N, Tomiyama Y, et al. Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization. Dig Dis Sci. 2006;51(2):352–358.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Guo L, Huang Q, et al. Observation of immediate and mid-term effects of partial spleen embolization in reducing hepatic venous pressure gradient. Medicine (Baltimore). 2019;98(47):e17900.
   PubMed Web of Science ®Google Scholar
• Escorsell A, Bandi JC, Andreu V, et al. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology. 2001;120(1):161–169.
   PubMed Web of Science ®Google Scholar
• Cirera I, Feu F, Luca A, et al. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation. Hepatology. 1995;22(1):106–111.
   PubMed Web of Science ®Google Scholar
• Naeije R, Hallemans R, Mols P, et al. Effect of vasopressin and somatostatin on hemodynamics and blood gases in patients with liver cirrhosis. Crit Care Med. 1982;10(9):578–582.
   PubMed Web of Science ®Google Scholar
• Merkel C, Gatta A, Zuin R, et al. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension. Digestion. 1985;32(2):92–98.
   PubMed Web of Science ®Google Scholar
• Bosch J. Effect of pharmacological agents on portal hypertension: a haemodynamic appraisal. Clin Gastroenterol. 1985;14(1):169–184.
   PubMedGoogle Scholar
• Lin HC, Tsai YT, Lee FY, et al. Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosis. J Hepatol. 1989;9(3):326–330.
   PubMed Web of Science ®Google Scholar
• Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology. 1981;80(3):518–525.
   PubMed Web of Science ®Google Scholar
• Thulin L, Tyden G, Samnegard H, et al. Treatment of bleeding oesophageal varices with somatostatin. Acta Chir Scand. 1979;145(6):395–398.
   PubMedGoogle Scholar
• Tyden G, Sammegard H, Thulin L, et al. Treatment of bleeding esophageal varices with somatostatin. The New England Journal of Medicine. 1978;299(26):1466–1467.
   PubMed Web of Science ®Google Scholar
• Raptis S, Zoupas C. Somatostatin not helpful in bleeding esophageal varices. The New England Journal of Medicine. 1979;300(13):736–737.
   PubMed Web of Science ®Google Scholar
• Hsia HC, Lin HC, Lee FY, et al. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis. J Gastroenterol Hepatol. 1993;8(1):15–20.
   PubMed Web of Science ®Google Scholar
• Gusberg RJ, Peterec SM, Sumpio BE, et al. Splenomegaly and variceal bleeding–hemodynamic basis and treatment implications. Hepatogastroenterology. 1994;41(6):573–577.
   PubMedGoogle Scholar
• Chikamori F, Kuniyoshi N, Kawashima T, et al. Short-term portal hemodynamic effects of partial splenic embolization for hypersplenism. Hepatogastroenterology. 2007;54(78):1847–1849.
   PubMedGoogle Scholar
• Boyer TD, Haskal ZJ. American Association for the Study of Liver D. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41(2):386–400.
   PubMed Web of Science ®Google Scholar
• Rossle M, Siegerstetter V, Olschewski M, et al. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterology. 2001;96(12):3379–3383.
   PubMed Web of Science ®Google Scholar
• Koconis KG, Singh H, Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: a review of the english language literature. J Vasc Interv Radiol. 2007;18(4):463–481.
   PubMed Web of Science ®Google Scholar
• Avgerinos A, Nevens F, Raptis S, et al. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet. 1997;350(9090):1495–1499.
   PubMed Web of Science ®Google Scholar
• Burroughs AK, McCormick PA, Hughes MD, et al. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology. 1990;99(5):1388–1395.
   PubMed Web of Science ®Google Scholar
• Valenzuela JE, Schubert T, Fogel MR, et al. A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology. 1989;10(6):958–961.
   PubMed Web of Science ®Google Scholar
• Gotzsche PC, Gjorup I, Bonnen H, et al. Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis. BMJ. 1995;310(6993):1495–1498.
   PubMedGoogle Scholar
• Wells M, Chande N, Adams P, et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther. 2012;35(11):1267–1278.
   PubMed Web of Science ®Google Scholar
• Schubert ML. Gastric exocrine and endocrine secretion. Curr Opin Gastroenterol. 2009;25(6):529–536.
   PubMed Web of Science ®Google Scholar